Badie, A., Gaiddon, C., & Mellitzer, G. (2022). Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target? Cancers, 14(21), 5472. https://doi.org/10.3390/cancers14215472
Bersuder, E., Terciolo, C., Lechevrel, M., Martin, E., Quesnelle, C., Freund, J.-N., Reimund, J.-M., & Gross, I. (2022). Mesalazine initiates an anti-oncogenic β-catenin / MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 146, 112543. https://doi.org/10.1016/j.biopha.2021.112543
Collard, M. K., Tourneur-Marsille, J., Uzzan, M., Albuquerque, M., Roy, M., Dumay, A., Freund, J.-N., Hugot, J.-P., Guedj, N., Treton, X., Panis, Y., & Ogier-Denis, E. (2022). The appendix orchestrates T-cell mediated immunosurveillance in colitis-associated cancer. Cellular and Molecular Gastroenterology and Hepatology, S2352-345X(22)00230-2. https://doi.org/10.1016/j.jcmgh.2022.10.016
De Azevedo, J., Mourtada, J., Bour, C., Devignot, V., Schultz, P., Borel, C., Pencreach, E., Mellitzer, G., Gaiddon, C., & Jung, A. C. (2022). The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response. Cells, 11(18), 2866. https://doi.org/10.3390/cells11182866
Delhorme, J.-B., Bersuder, E., Terciolo, C., Vlami, O., Chenard, M.-P., Martin, E., Rohr, S., Brigand, C., Duluc, I., Freund, J.-N., & Gross, I. (2022). CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 147, 112630. https://doi.org/10.1016/j.biopha.2022.112630
Giolito, M. V., & Plateroti, M. (2022). Thyroid hormone signaling in the intestinal stem cells and their niche. Cellular and Molecular Life Sciences: CMLS, 79(9), 476. https://doi.org/10.1007/s00018-022-04503-y
Goïta, A. A., & Guenot, D. (2022). Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7. Cancers, 14(7), 1810. https://doi.org/10.3390/cancers14071810
Passet, M., Kim, R., Gachet, S., Sigaux, F., Chaumeil, J., Galland, A., Sexton, T., Quentin, S., Hernandez, L., Larcher, L., Bergugnat, H., Ye, T., Karasu, N., Caye-Eude, A., Heizmann, B., Duluc, I., Chevallier, P., Rousselot, P., Huguet, F., … Clappier, E. (2022). Concurrent CDX2 cis-deregulation and UBTF-ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL. Blood, blood.2021014723. https://doi.org/10.1182/blood.2021014723
Sirakov, M., & Plateroti, M. (2022). Thyroid Hormone Signaling and Function: News from Classical and Emerging Models. Cells, 11(3), 453. https://doi.org/10.3390/cells11030453
Venkatasamy, A., Guerin, E., Reichardt, W., Devignot, V., Chenard, M. P., Miguet, L., Romain, B., Jung, A. C., Gross, I., Gaiddon, C., & Mellitzer, G. (2022). Morpho-functional analysis of patient-derived xenografts reveals differential impact of gastric cancer and chemotherapy on the tumor ecosystem, affecting immune check point, metabolism, and sarcopenia. Gastric Cancer. https://doi.org/10.1007/s10120-022-01359-w